Summit Health Advisors

While most digital health leaders are greatly optimistic about 2025, next year could prove to be a make-or-break year for many companies. Why? Key findings from our new Digital Health Go-to-Market Report:  - 4-in-5 digital health executives are planning to raise capital in 2025 - 44% of executives fear heightened competition from large incumbents - 41% of executives are worried about cash flow and making payroll  - 38% of executives say their revenue is overdependent on too few customers Check out our inaugural survey of more than 100 digital health leaders to learn more about the realities of taking a digital health product to market. https://lnkd.in/g5v8ZyY4 Our report provides insights into the top go-to-market trends and strategies for digital health firms, including competitive positioning, pricing strategy, sales and marketing, ROI and validations, and more. Discover the most critical challenges and priorities facing digital health leaders in 2025!

We’re thrilled to announce the launch of The Ascent, our new newsletter dedicated to all things network effects and platform strategy in healthcare. In each monthly issue, we’ll explore: • Expert analysis and fresh perspectives on vital network effects topics and companies in healthcare. • Cross-industry insights on multi-sided platforms—and lessons for healthcare. • Featured research and best practices from network effects experts. • Recent funding news and analysis for digital health platforms. In this issue, we dig deep into how Tempus AI leveraged network effects to become the dominant data platform of the decade. Whether you're an innovator, investor, policy expert, or just curious about how platforms and marketplaces are transforming healthcare, The Ascent is your go-to resource for new ideas and inspiration. 👉 Subscribe now: https://lnkd.in/gjf9Ph8B #TheAscent #NetworkEffects #DigitalHealth 

Today we released our inaugural list of the Top 42 Digital Health Platforms! The Top 42 is Summit Health Advisors’ annual ranking of the most promising network effects-driven companies in healthcare. These companies are forging new connections, efficiencies and trust across the healthcare system, helping to solve some of healthcare’s most deeply rooted challenges. Our research team evaluated over 775 digital health platform companies, across more than 25 indicators and 42 data points, to determine this year's most dominant, high-growth platform businesses. Check out the companies and our selection methodology here: https://lnkd.in/gryarJRE Congratulations to all the Top 42 companies! Lantern Nomi Health Wheel Innovaccer Medicom Technologies Inc. Carrum Health Angle Health b.well Connected Health Redox Vim Datavant DNAnexus Evidation Turquoise Health Clipboard Health Headway IntelyCare Medely Solv. Ada Health Papa Zocdoc Nomad Health Nursa Sesame Summus Healthcare Scan.com SafeRide Health Waltz Health Devoted Health Rightway Unite Us House Rx RxLightning Sempre Health Parachute Health Elation Health Aledade Inc Stellar Health DocStation

Apple. Salesforce. Walmart. Nike. Best Buy. The Home Depot.   What do they each have in common?   Each company began as a traditional pipeline business, meaning they created value in a linear manner with a one-time flow of value from producer to consumer.    Yet, in order to achieve their current market dominance, each of these companies embraced a platform business strategy that unlocked new revenue growth, consumer loyalty and shareholder value.   In our most recent research, we explore how enterprise healthcare organizations can follow in the footsteps of these industry titans, and leverage network effects to launch new offerings to enhance their core business. https://lnkd.in/g-98B59p

Come hear our managing director Seth Joseph lead a rare discussion on the role of monopolies, competition and innovation in healthcare at HLTH USA.

“Teams that are clear on their mission and have demonstrated they can navigate through noise and distractions to do the right things will have the best shot at success. This is healthcare – it’s high stakes and a firm compass on principles is very valuable.” In a recent conversation, Teresa Lee, Managing Director at OMERS Growth Equity, discusses the power of platforms in healthcare and shares insights into her investment strategy for 2024. Teresa is an ardent digital health platform investor and board member, helping to scale some of today’s most formidable platform companies, including Aledade, Inc., Evidation, Carrum Health and Innovaccer. https://lnkd.in/gZ4tP9gE

For most digital health SaaS companies, the multitude of stakeholders and interactions in healthcare creates added complexities and barriers to commercialization. Yet these interactions--prescriptions, referrals, claims and hundreds of others--are the blood vessels coursing through the veins and arteries of the healthcare system, keeping it functioning and alive. For the platform companies (and their investors) that can facilitate these interactions with greater efficiency or reliability, there is tremendous value to be captured. Check out our new Digital Health Investor Report to see the full healthcare interaction map and access new research on the most attractive platform interactions (markets) in healthcare. https://lnkd.in/d2jBgqZf Appreciate the wise words from top digital health platform investors featured in the report: Julie Yoo at a16z Bio + Health, Scott Barclay at Insight Partners, Marta G. Zanchi at Nina Capital and Carl Bradford Byers 🚑 at F-Prime Capital.

"Once a flywheel like this is in motion, it’s difficult to disrupt, and we’re excited to continue building upon our market-leading position today." In a recent conversation, Anurati Mathur, co-founder and CEO at Sempre Health, discusses how her platform is connecting pharmaceutical companies and health plans in new ways to save patients money. This interview is the second in a series of conversations with influential digital health platform founders and investors. https://lnkd.in/gZk2_73e

Platform businesses make up 7 of the 12 largest companies and over 60% of all unicorn companies in the world. They grow faster, reach higher profitability and deliver greater shareholder value. Yet, less than 15% of all digital health investment goes into platform businesses. With healthcare platforms representing a combined $1 trillion TAM, there is a massive missed opportunity for investors. But which markets present the greatest opportunity for investment? Check out our new Digital Health Investor Report to access new data and research that sheds light on the most attractive platform markets in healthcare. https://lnkd.in/d2jBgqZf Thankful for the wisdom shared by top digital health platform investors, including Julie Yoo at a16z Bio + Health, Scott Barclay at Insight Partners, Marta G. Zanchi at Nina Capital and Carl Bradford Byers 🚑 at F-Prime Capital.

"The future of healthcare is going to be around simplifying things for the consumer. Giving the consumers more control over their health." In a recent conversation, doug hirsch, co-founder and Chief Mission Officer at GoodRx, discusses what it takes to scale one of the leading platform companies in healthcare. This interview is the first in a series of conversations with influential digital health platform founders and investors. https://lnkd.in/gp-v3xXA